Inventera: 투자판단관련주요경영사항(임상시험결과) (자기공명 관절조영술(MRA) 특화 조영제 INV-002(NEMO-103주)의 제3상 임상시험결과)

Received final clinical study report for Phase 3 trial of contrast agent INV-002

An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).

• 09.17 ★★★ Filed Investigational New Drug (IND) application with US FDA for Phase 1 trial of contrast agent INV-003